Is TCF7L2 useful for weight loss?

TCF7L2 is a gene strongly associated with type 2 diabetes risk, particularly through variants like rs7903146. Some studies have investigated whether carriers of the risk allele respond differently to weight loss interventions, such as showing less weight reduction or poorer glycemic control. However, the evidence is inconsistent: while some observational studies suggest a modest effect, randomized controlled trials demonstrating a direct benefit of TCF7L2 testing for weight loss are lacking. Moreover, the effect size is small and overshadowed by many other factors (diet, exercise, medications). Therefore, a genetic test for TCF7L2 alone is not sufficient to guide weight loss and is not clinically recommended. The predictive value is limited, and there is a risk of overinterpretation. Evidence: mixed – strong association with diabetes, but weak and inconsistent data for weight loss. Sources: No specific studies provided in the given context.